Form 4: Curis Inc. Director Greenacre Martyn D. Reports Stock Option Grant

Director Martyn D. Greenacre reports the acquisition of stock options in Curis Inc. following shareholder approval of an amendment to the company's stock incentive plan.

Summary

• Martyn D. Greenacre, a director of Curis Inc., filed a Form 4 disclosing a transaction involving derivative securities.
• On May 20, 2025, Greenacre acquired 14,400 non-qualified stock options with an exercise price of $3.13.
• These options were granted on January 28, 2025, contingent upon shareholder approval of Amendment No. 1 to the Fifth Amended and Restated 2010 Stock Incentive Plan.
• Shareholder approval was obtained on May 20, 2025, at the annual meeting.
• The options vest as to 100% of the underlying shares on January 28, 2026, and expire on January 27, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of stock options to a director is a standard practice and indicates alignment of interests with shareholders. The shareholder approval of the stock incentive plan amendment is also a positive sign.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• Shareholder approval of the stock incentive plan amendment indicates support for the company's compensation strategy.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize and retain key personnel, aligning their interests with the long-term success of the company. This grant to a director is consistent with standard compensation practices.

Comparison to Industry Standards

• Stock option grants to directors are a common practice across the biotechnology industry.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options as part of their director compensation packages.
• The vesting schedule and exercise price are typical for such grants, aligning with industry norms.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning the director's interests with the company's performance.
• Employees may see the shareholder approval of the stock incentive plan amendment as a positive development, potentially leading to future grants.

Key Dates

Keywords

Form 4, stock options, Curis Inc., director, Greenacre, beneficial ownership, derivative securities, shareholder approval, stock incentive plan